David W Johns
Engineering in Baltimore, MD

License number
Pennsylvania ET003099
Category
Engineers
Type
Engineer in Training
Address
Address 2
Baltimore, MD 21234
Pennsylvania

Personal information

See more information about David W Johns at radaris.com
Name
Address
Phone
David Johns, age 54
512 Hansen Rd, King of Prussia, PA 19406
(610) 337-8744
David Johns
5206 Duke Ct, Frederick, MD 21703
(301) 662-4070
David Johns
45 Mcmurray Rd APT 219, Pittsburgh, PA 15241
(724) 225-4085
David Johns, age 75
4611 Pearson Ave, Philadelphia, PA 19114
(215) 331-6784
David Johns, age 54
606 Elizabeth St, Coalport, PA 16627
(814) 378-5393

Professional information

David Johns Photo 1

Biotechnology Professional

Location:
Baltimore, Maryland Area
Industry:
Biotechnology
Work:
BioStorage Lab Services, LLC 2009 - 2010 - CSO
Education:
The Johns Hopkins University School of Medicine 1995 - 1998
The Johns Hopkins University


David Johns Photo 2

David Johns - Baltimore, MD

Work:
Bureau of Revenue Collections Tax Sale Unit
Office Clerk I
University Of Maryland - Baltimore, MD
Assistant Laboratory Animal Technician
Linens N Things - Ellicott City, MD
Floor Associate
Better Business Bureau - Baltimore, MD
Volunteer Coordinator
Empire Milk Distributors - Catonsville, MD
Order Clerk and Delivery Assistant
Education:
Catonsville High School - Catonsville, MD
High School Diploma in HISTORY
Skills:
Detailed in Maintaining Files and Records, Microsoft Office Suite: Word, Excel, PowerPoint


David Johns Photo 3

Operations Manager At Bond Distributing Company

Position:
Operations Manager at Bond Distributing Company
Location:
Baltimore, Maryland Area
Industry:
Warehousing
Work:
Bond Distributing Company since May 1983 - Operations Manager
Skills:
Warehousing


David Johns Photo 4

Inducible Genetic Suppression Of Cellular Excitability

US Patent:
6214620, Apr 10, 2001
Filed:
Sep 29, 1999
Appl. No.:
9/407945
Inventors:
David C. Johns - Elkridge MD
Eduardo Marban - Lutherville MD
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
C12N 1585, C12N 1563, C12N 500, C07H 2104
US Classification:
435455
Abstract:
Graded, reversible suppression of cellular excitability represents a logical goal of therapy for epilepsy and intractable pain, as well as for cardiac arrhythmias. To achieve such suppression, "electrical silencing" genes are transferred into cells with sensitive control of transgene expression. For example, an ecdysone-inducible promoter drives the expression of inwardly rectifying potassium channels in polycistronic adenoviral vectors. While normal electrical activity is not affected, after the induction of gene expression excitability is suppressed.